Mackenzie Financial Portfolio holdings
AUM
$77.2B
1-Year Return
22.51%
This Quarter Return
+4.92%
1 Year Return
+22.51%
3 Year Return
+61.14%
5 Year Return
+128.52%
10 Year Return
+216.87%
AUM
$65.4B
AUM Growth
+$1.3B
(+2%)
Cap. Flow
-$1.34B
Cap. Flow
% of AUM
-2.05%
Top 10 Holdings %
Top 10 Hldgs %
22.22%
Holding
1,682
New
170
Increased
573
Reduced
626
Closed
177
Top Buys
| 1 |
Brookfield Infrastructure Partners
BIP
|
+$181M |
| 2 |
S&P Global
SPGI
|
+$176M |
| 3 |
CAE Inc
CAE
|
+$165M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$145M |
| 5 |
Bank of Montreal
BMO
|
+$106M |
Top Sells
| 1 |
Jacobs Solutions
J
|
+$372M |
| 2 |
Brookfield Infrastructure
BIPC
|
+$203M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$154M |
| 4 |
United Rentals
URI
|
+$151M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$144M |
Sector Composition
| 1 | Financials | 20.6% |
| 2 | Technology | 19.21% |
| 3 | Industrials | 12.87% |
| 4 | Healthcare | 9.85% |
| 5 | Energy | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Viavi Solutions
VIAV
$2.66B
| $234K | ﹤0.01% |
20,572
| – | – |
|
1277
The RealReal
REAL
$1.02B
| $234K | ﹤0.01% |
100,000
-5,490
| -5% | -$12.8K |
|
1278
PTC Therapeutics
PTCT
$4.63B
| $233K | ﹤0.01% |
5,627
-8,102
| -59% | -$336K |
|
1279
ATN International
ATNI
$235M
| $232K | ﹤0.01% |
+6,258
| New | +$232K |
|
1280
Avient
AVNT
$3.34B
| $231K | ﹤0.01% |
5,623
| – | – |
|
|
NATI
1281
DELISTED
National Instruments Corp
NATI
| $231K | ﹤0.01% |
+4,023
| New | +$231K |
|
1282
Arcosa
ACA
$4.72B
| $230K | ﹤0.01% |
+3,016
| New | +$230K |
|
1283
Mr. Cooper
COOP
$14B
| $230K | ﹤0.01% |
+4,510
| New | +$230K |
|
1284
NorthWestern Energy
NWE
$3.47B
| $230K | ﹤0.01% |
+4,017
| New | +$230K |
|
1285
Adient
ADNT
$1.92B
| $229K | ﹤0.01% |
5,874
| – | – |
|
1286
Roivant Sciences
ROIV
$9.4B
| $229K | ﹤0.01% |
23,456
-17,739
| -43% | -$173K |
|
1287
East-West Bancorp
EWBC
$14.9B
| $228K | ﹤0.01% |
+4,278
| New | +$228K |
|
1288
Liquidity Services
LQDT
$845M
| $228K | ﹤0.01% |
+13,841
| New | +$228K |
|
1289
Cadence Bank
CADE
$6.94B
| $228K | ﹤0.01% |
11,334
| – | – |
|
1290
Scansource
SCSC
$948M
| $227K | ﹤0.01% |
7,632
-2,000
| -21% | -$59.4K |
|
|
BZUN
1291
Baozun
BZUN
$230M
| $226K | ﹤0.01% |
+54,715
| New | +$226K |
|
1292
Arrowhead Research
ARWR
$3.99B
| $226K | ﹤0.01% |
+6,419
| New | +$226K |
|
1293
Lear
LEA
$5.76B
| $226K | ﹤0.01% |
1,556
-233
| -13% | -$33.8K |
|
1294
Interface
TILE
$1.6B
| $225K | ﹤0.01% |
+24,827
| New | +$225K |
|
1295
Teva Pharmaceuticals
TEVA
$22.4B
| $224K | ﹤0.01% |
29,954
| – | – |
|
1296
FirstCash
FCFS
$6.46B
| $224K | ﹤0.01% |
2,388
| – | – |
|
1297
Prestige Consumer Healthcare
PBH
$3.2B
| $223K | ﹤0.01% |
3,771
| – | – |
|
1298
TriNet
TNET
$3.3B
| $223K | ﹤0.01% |
2,320
-9,592
| -81% | -$921K |
|
1299
Ocular Therapeutix
OCUL
$2.27B
| $221K | ﹤0.01% |
44,173
-21,800
| -33% | -$109K |
|
1300
Resources Connection
RGP
$167M
| $220K | ﹤0.01% |
13,782
+3,470
| +34% | +$55.3K |
|